Literature DB >> 20820917

The correlation of extent and grade of inflammation with serum PSA levels in patients with IV prostatitis.

Li Gui-Zhong1, Man Libo, Huang Guanglin, Wang Jianwei.   

Abstract

OBJECTIVES: The inflammation was categorized more profoundly, using the standardized histopathological classification system for chronic prostatitis of NIH, to determine the influence of prostatic inflammation on serum PSA levels.
METHODS: The study included 120 patients who underwent transperineal ultrasound-guided prostate biopsy. The patients were divided into groups using 3 grades for the extent, the location and the aggressiveness of prostate inflammation. The serum tPSA levels, fPSA levels, %fPSA, and PSAD in each group were compared.
RESULTS: Of 120 patients, 80 with benign prostatic tissue in their biopsy specimens met the inclusion criteria, excluding 40 cases with prostate cancer. The inflammation was present in 46(57.5%) of 80 cases. The extent of inflammation correlated positively with the total PSA level (r = 0.6, P < 0.001), fPSA (r = 0.5, P = 0.001) and PSAD (r = 0.6, P < 0.001). The grade of inflammation correlated positively with the total PSA level (r = 0.5, P < 0.001), fPSA (r = 0.4, P = 0.008) and PSAD (r = 0.7, P < 0.001). A negative correlation was found between the grade of inflammation and %fPSA (r = -0.4, P = 0.013).
CONCLUSIONS: If the elevation of serum PSA is thought to be caused by asymptomatic prostatitis with high aggressiveness score in BPH patients without clinical prostatitis, it might prevent unnecessary repeated biopsies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820917     DOI: 10.1007/s11255-010-9825-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients.

Authors:  V Serretta; A Catanese; G Daricello; R Liotta; R Allegro; A Martorana; F Aragona; D Melloni
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-07-17       Impact factor: 5.554

2.  Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study.

Authors:  Lucila Heloisa Simardi; Marcos Tobias-MacHado; Guilherme Tommasi Kappaz; Patricia Taschner Goldenstein; Jeannette M Potts; Eric Roger Wroclawski
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

3.  Cytokine variations in patients with hormone treated prostate cancer.

Authors:  G J Wise; V K Marella; G Talluri; D Shirazian
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

4.  Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates.

Authors:  P N Brawn; V O Speights; D Kuhl; M Riggs; A M Spiekerman; R G McCord; K S Coffield; D T Stewart; M L Lind
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860

Review 5.  Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Authors:  T J Polascik; J E Oesterling; A W Partin
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

6.  Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.

Authors:  P H Schatteman; L Hoekx; J J Wyndaele; W Jeuris; E Van Marck
Journal:  Eur Urol       Date:  2000-04       Impact factor: 20.096

7.  Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients.

Authors:  Engin Kandirali; Cetin Boran; Erdinc Serin; Atilla Semercioz; Ahmet Metin
Journal:  Urology       Date:  2007-10       Impact factor: 2.649

8.  The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy.

Authors:  L A Begley; S Kasina; J MacDonald; J A Macoska
Journal:  Cytokine       Date:  2008-06-24       Impact factor: 3.861

9.  Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation.

Authors:  Onder Yaman; Cağatay Göğüş; Ozden Tulunay; Zafer Tokatli; Eriz Ozden
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

10.  Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis.

Authors:  Minoru Kobayashi; Akinori Nukui; Tatsuo Morita
Journal:  Urol Int       Date:  2008-03-19       Impact factor: 2.089

View more
  10 in total

1.  Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.

Authors:  B A Rybicki; O N Kryvenko; Y Wang; M Jankowski; S Trudeau; D A Chitale; N S Gupta; A Rundle; D Tang
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-12-01       Impact factor: 5.554

Review 2.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

3.  Infections and inflammation in prostate cancer.

Authors:  Karen S Sfanos; William B Isaacs; Angelo M De Marzo
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

4.  Clinical Importance of Histopathological Inflammation in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Prospective Study of 222 Patients.

Authors:  Thibault Meert; Evert Baten; Koenraad van Renterghem
Journal:  Curr Urol       Date:  2017-07-30

5.  Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.

Authors:  D M Moreira; J C Nickel; G L Andriole; R Castro-Santamaria; S J Freedland
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-19       Impact factor: 5.554

6.  A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.

Authors:  Debika Biswal Shinohara; Ajay M Vaghasia; Shu-Han Yu; Tim N Mak; Holger Brüggemann; William G Nelson; Angelo M De Marzo; Srinivasan Yegnasubramanian; Karen S Sfanos
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

7.  Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen.

Authors:  Jiang Feng; Feng Gang; Xiao Li; Tang Jin; Huang Houbao; Cao Yu; Li Guorong
Journal:  Int Urol Nephrol       Date:  2013-06-19       Impact factor: 2.370

8.  Assessment of a new point-of-care system for detection of prostate specific antigen.

Authors:  Steffen Rausch; Joerg Hennenlotter; Josef Wiesenreiter; Andrea Hohneder; Julian Heinkele; Christian Schwentner; Arnulf Stenzl; Tilman Todenhöfer
Journal:  BMC Urol       Date:  2016-01-19       Impact factor: 2.264

9.  Multi-factors including Inflammatory/Immune, Hormones, Tumor-related Proteins and Nutrition associated with Chronic Prostatitis NIH IIIa+b and IV based on FAMHES project.

Authors:  Yang Chen; Jie Li; Yanling Hu; Haiying Zhang; Xiaobo Yang; Yonghua Jiang; Ziting Yao; Yinchun Chen; Yong Gao; Aihua Tan; Ming Liao; Zhen Lu; Chunlei Wu; Xiaoyin Xian; Suchun Wei; Zhifu Zhang; Wei Chen; Gong-Hong Wei; Qiuyan Wang; Zengnan Mo
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

10.  Prevalence of and risk factors for asymptomatic inflammatory (NIH-IV) prostatitis in Chinese men.

Authors:  Chunlei Wu; Zhifu Zhang; Zheng Lu; Ming Liao; Youjie Zhang; Yuanliang Xie; Xuefeng Guo; Xiaoxiang Yu; Xiaobo Yang; Yong Gao; Aihua Tan; Zengnan Mo
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.